A community effort to track commercial single-cell and spatial 'omic technologies and business trends

Joachim De Jonghe^#¹, James W Opzoomer^#^{2

3}, Amaia Vilas-Zornoza^#³, Peter Crane^#⁴, Benedikt S Nilges⁵, Marco Vicari⁶, Hower Lee^{7

8}, David Lara-Astiaso^{9

10}, Torsten Gross³, Jörg Morf¹¹, Kim Schneider¹², Juliana Cudini³, Lorenzo Ramos-Mucci³, Dylan Mooijman¹³, Katarína Tiklová⁸, Sergio Marco Salas^{7

8}, Christoffer Mattsson Langseth^{7

8}, Nachiket D Kashikar⁵, Charles E S Roberts^{3

14}; scTrends Consortium; Joakim Lundeberg⁶, Mats Nilsson⁸, Alex K Shalek^{3

15

16

17}, Adam P Cribbs^{4

18

19}, Jake P Taylor-King²⁰

Collaborators, Affiliations

Collaborators

scTrends Consortium:
Christoffer Mattsson Langseth, Eli M Carrami, Rebecca McIntyre, Casey Benjamin Swerner, Edith M Hessel, Chantriolnt-Andreas Kapourani, Cristian Regep, Denis Schapiro

Affiliations

¹ Francis Crick Institute, London, UK.
² Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK.
³ Relation Therapeutics, London, UK.
⁴ Caeruleus Genomics, Oxford, UK.
⁵ OMAPiX GmbH, Langenfeld, Germany.
⁶ Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Solna, Sweden.
⁷ spatialist AB, Stockholm, Sweden.
⁸ Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden.
⁹ Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.
¹⁰ Department of Hematology, University of Cambridge, Cambridge, UK.
¹¹ Skyhawk Therapeutics, Basel, Switzerland.
¹² Roche, Basel, Switzerland.
¹³ Single Cell Discoveries, Utrecht, the Netherlands.
¹⁴ ARK Investment Management, St. Petersburg, FL, USA.
¹⁵ Institute for Medical Engineering and Science, Department of Chemistry and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
¹⁶ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
¹⁷ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
¹⁸ Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, National Institute of Health Research Oxford Biomedical Research Unit (BRU), University of Oxford, Oxford, UK.
¹⁹ Oxford Centre for Translational Myeloma Research University of Oxford, Oxford, UK.
²⁰ Relation Therapeutics, London, UK. jake@relationrx.com.

^# Contributed equally.

PMID: 39020213
DOI: 10.1038/s41587-024-02305-0

A community effort to track commercial single-cell and spatial 'omic technologies and business trends

Joachim De Jonghe et al. Nat Biotechnol. 2024 Jul.

. 2024 Jul;42(7):1017-1023.

doi: 10.1038/s41587-024-02305-0.

Authors

Collaborators

scTrends Consortium:
Christoffer Mattsson Langseth, Eli M Carrami, Rebecca McIntyre, Casey Benjamin Swerner, Edith M Hessel, Chantriolnt-Andreas Kapourani, Cristian Regep, Denis Schapiro

Affiliations

¹ Francis Crick Institute, London, UK.
² Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK.
³ Relation Therapeutics, London, UK.
⁴ Caeruleus Genomics, Oxford, UK.
⁵ OMAPiX GmbH, Langenfeld, Germany.
⁶ Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Solna, Sweden.
⁷ spatialist AB, Stockholm, Sweden.
⁸ Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden.
⁹ Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.
¹⁰ Department of Hematology, University of Cambridge, Cambridge, UK.
¹¹ Skyhawk Therapeutics, Basel, Switzerland.
¹² Roche, Basel, Switzerland.
¹³ Single Cell Discoveries, Utrecht, the Netherlands.
¹⁴ ARK Investment Management, St. Petersburg, FL, USA.
¹⁵ Institute for Medical Engineering and Science, Department of Chemistry and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
¹⁶ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
¹⁷ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
¹⁸ Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, National Institute of Health Research Oxford Biomedical Research Unit (BRU), University of Oxford, Oxford, UK.
¹⁹ Oxford Centre for Translational Myeloma Research University of Oxford, Oxford, UK.
²⁰ Relation Therapeutics, London, UK. jake@relationrx.com.

^# Contributed equally.

PMID: 39020213
DOI: 10.1038/s41587-024-02305-0

No abstract available

PubMed Disclaimer

References

1. Marx, V. Nat. Methods 18, 9–14 (2021). - DOI - PubMed
1. Nat. Methods 17, 1 (2020).
1. Replogle, J. M. et al. Cell 185, 2559–2575.e28 (2022). - DOI - PubMed - PMC
1. Lara-Astiaso, D. et al. Nat. Genet. 55, 1542–1554 (2023). - DOI - PubMed - PMC
1. Zheng, G. X. Y. et al. Nat. Commun. 8, 14049 (2017). - DOI - PubMed - PMC

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A community effort to track commercial single-cell and spatial 'omic technologies and business trends

Collaborators

Affiliations

A community effort to track commercial single-cell and spatial 'omic technologies and business trends

Authors

Collaborators

Affiliations

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources